Medical devices can be complicated to operate, so pharmaceutical manufacturers have a legal duty to write up easy-to-understand instructions for use (IFU) on any medical devices put out on the market.
Exactly what needs to be included is laid out in writing in both the United States and the European Union, with both regions having their own requirements that medical companies must follow.
It is vital to understand medical device regulations in the US and in the EU to ensure safe and effective use of medical devices by end-users who might not be familiar with how they work. IFUs reduce the liability of a pharmaceutical company as well, so it’s within your best interest to focus on writing IFUs.
Read on to learn more about IFUs, their regulations, and other key information you need to know.
The US has several federal agencies responsible for controlling and regulating public safety. Of them, the Health and Body portion is responsible for, among other things, medical devices. The Food and Drug Administration (FDA), acting under the Federal Food, Drug and Cosmetic Act (FFDCA), has created the Code of Federal Regulations Title 21 that covers medical devices and pharmaceuticals.
IFUs specifically are mentioned in the section regarding medical device labeling. “Labels” can take the form of either the sticker on the container, a brochure, booklet, manual, direction sheets, tags, or other similar accompanying literature.
While not exactly “instructions for use” per se, the labels you add to your medical devices are also under regulation by the FDA, so we’ll cover them now.
Part 801 of the CFR mentioned previously is our point of focus, as it specifies:
Labeling is only a portion of the medical device compliance process. Various other features and documentation must be included as well.
This portion of the FDA’s rulings has to do with “current Good Manufacturing Practices” when it comes to manufacturing and releasing medical devices. In terms of Instructions for Use, the requirements are:
The manufacturer must additionally have a system in place for receiving and evaluating consumer complaints and potentially responding with investigations.
The FDA publishes the Guidance on Medical Device Patient Labelling to help pharmaceutical companies write comprehensive instruction manuals for their medical devices. Some of what it asks for are the following.
If a medical device is either not approved for marketing or is under current clinical evaluation, then it is considered an investigational device. As a result, there must be a clear indicator on the product label saying so. The FDA requires that investigational devices have the Investigational Device Exemption (IDE) so that information can be collected as part of premarket approval.
The FDA also specifies
a series of IFU regulations regarding in vitro diagnostic devices, medical devices using biological samples to check on the status of one’s health.
Compared to analogous legislation in the US, European IFU medical device validation regulations largely separate the requirements for device instructions, packaging, and labeling. They take the form of the (EU) 2017/745 Regulation.
The regulation covers all types of medical devices and their accessories but explicitly does not cover in vitro diagnostic devices, cosmetics, food, or medicinal products. For in vitro diagnostic medical devices, the
Regulation (EU) 2017/746 instead will take over.
The EU categorizes medical devices into 4 categories: Class I, Class IIa, Class IIb, and Class III.
Only devices in Class I are exempt from official assessment by a Notified Body, and Instructions for Use are only required for Class IIb and Class III devices since they are complex enough to call for them. In vitro diagnostic devices have a separate but similar classification system of Class A, B, C, and D.
The EU Regulation contains plenty of data points that must be included in the Instructions for Use for a medical device. We recommend going through and finding all the sections that mention IFU and building a checklist from there. A few requirements we’ve picked out are the following.
In vitro medical devices are also covered under the Regulation, and the regulatory requirements are similarly comprehensive. To ensure compliance, we recommend:
Another question worth asking is who to entrust your IFU writing to. The EU regulation actually uses the term “competent person,” which refers to anybody with experience, education, or qualifications in a particular task.
Whether you have a dedicated writer or a team of experienced IFU specialists, it’s your task to identify what needs to be done and who is competent in the related fields.
Pharmaceutical manufacturing companies have an opportunity to prove compliance with certain essential requirements by using harmonized standards. The C-type standard, for instance, covers a given category of devices, whether they are X-ray equipment, radiotherapy devices, or otherwise. Examples include:
There are obviously far more out there, so double-check with the Regulations to see which ones are applicable to you.
Writing the Instructions for Use is about more than just technical writing. You have to tell your writers what to include and what information is accurate. To that end, businesses must gather and analyze all the technical specifications, compliance procedures, storage instructions, marketing objectives, and other relevant data first. Doing so requires strong collaboration amongst multiple departments.
An information management process helps determine exactly how the IFU will be written, hence why the 82079 standard mentions it directly. The requirements include:
You don’t want to publish Instructions for Use only to realize that you accidentally left out an important detail or made a mistake in the writing process. An information management process minimizes this risk and ensures that your end user can use the medical device correctly.
EU regulations generally agree that safety instructions must be included with the product, while non-safety content can be provided separately like online. However, the legislation on medical devices is a little different.
Regulation (EU) No 207/2012, which understands that some instances may call for online instructions, specifies what circumstances or medical devices call for electronic rather than paper IFUs.
You also should look at translating your instructions too. EU Regulation calls on the languages accepted by the member states when the medical device comes out. Such a requirement extends to both the labeling and the instructions.
Medical devices are heavily regulated in both the United States and the European Union. The Instructions for Use specifically have their own requirements on top of the development and labeling of the device itself.
Because understanding all these regulations are paramount to increasing your compliance rate and boosting the effectiveness of your medical devices out on the field, it makes sense why pharmaceutical companies and device manufacturers are looking to give medical device training to their staff.
But where do you look for effective and up-to-date training resources from actual medical professionals?
Get in touch with the industry leader in pharmaceutical, biotech, and
medical device certifications. We have a training program for your specific needs.
Stay Informed
Since 2001 CfPIE has
Need help finding the right life sciences training courses? We can help you make the right choice based on your company's needs.
All Rights Reserved | CfPIE Inc. | Our courses and materials are copyrighted by CfPIE, Inc. and may not be used or reproduced without the written permission of CfPIE, Inc. management. | In partnership with CCC